Rationale and design of the OPTIME CHF trial: outcomes of a prospective trial of intravenous milrinone for exacerbations of chronic heart failure. [electronic resource]
Producer: 20000127Description: 15-22 p. digitalISSN:- 0002-8703
- Adolescent
- Cost-Benefit Analysis
- Female
- Heart Failure -- drug therapy
- Hospital Mortality
- Humans
- Injections, Intravenous
- Length of Stay
- Male
- Milrinone -- administration & dosage
- Phosphodiesterase Inhibitors -- administration & dosage
- Prospective Studies
- Quality of Life
- Survival Rate
- Treatment Outcome
- United States -- epidemiology
No physical items for this record
Publication Type: Clinical Trial; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.